181 related articles for article (PubMed ID: 28599389)
1. Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus.
Mavinkurve M; McGrath N; Johnston N; Moloney S; Murphy NP; Hawkes CP
J Pediatr Endocrinol Metab; 2017 May; 30(6):623-628. PubMed ID: 28599389
[TBL] [Abstract][Full Text] [Related]
2. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
3. Desmopressin administration in children with central diabetes insipidus: a retrospective review.
Ooi HL; Maguire AM; Ambler GR
J Pediatr Endocrinol Metab; 2013; 26(11-12):1047-52. PubMed ID: 23843580
[TBL] [Abstract][Full Text] [Related]
4. Desmopressin orally disintegrating tablet in Japanese patients with central diabetes insipidus: a retrospective study of switching from intranasal desmopressin.
Murakami T; Hatoko T; Nambu T; Matsuda Y; Matsuo K; Yonemitsu S; Muro S; Oki S
Endocr J; 2014; 61(8):773-9. PubMed ID: 24849384
[TBL] [Abstract][Full Text] [Related]
5. Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing.
Van der Kaay DC; Van Heel WJ; Dudink J; van den Akker EL
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):769-71. PubMed ID: 24670345
[TBL] [Abstract][Full Text] [Related]
6. [Central diabetes insipidus in the very young child. Treatment with oral desmopressin].
Fjellestad-Paulsen A; Crosnier H; Czernichow P
Arch Fr Pediatr; 1988 Dec; 45(10):787-90. PubMed ID: 3071285
[TBL] [Abstract][Full Text] [Related]
7. Isolated central diabetes insipidus in a newborn with congenital toxoplasmosis.
Karadag A; Erdeve O; Atasay B; Arsan S; Deda G; Ince E; Ocal G; Berberoglu M
J Pediatr Endocrinol Metab; 2006 Feb; 19(2):173-5. PubMed ID: 16562592
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
9. Oral desmopressin in neonatal diabetes insipidus.
Stick SM; Betts PR
Arch Dis Child; 1987 Nov; 62(11):1177-8. PubMed ID: 3688926
[TBL] [Abstract][Full Text] [Related]
10. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of diabetes insipidus with Minirin. Switch from nasal to oral administration].
Czernichow P
Ann Endocrinol (Paris); 1998 Dec; 59(5):407-9. PubMed ID: 9949892
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of desmopressin (DDAVP) in diabetes insipidus: solution vs tablets].
Rampazzo AL; Boscaro M; Mantero F; Piccitto R
Minerva Endocrinol; 1992; 17(1):37-41. PubMed ID: 1495453
[TBL] [Abstract][Full Text] [Related]
13. Management of central diabetes insipidus with oral desmopressin in a premature neonate.
Atasay B; Berberoğlu M; Günlemez A; Evliyaoğlu O; Adiyaman P; Unal S; Arsan S; Ocal G
J Pediatr Endocrinol Metab; 2004 Feb; 17(2):227-30. PubMed ID: 15055359
[TBL] [Abstract][Full Text] [Related]
14. Use of subcutaneous DDAVP in infants with central diabetes insipidus.
Blanco EJ; Lane AH; Aijaz N; Blumberg D; Wilson TA
J Pediatr Endocrinol Metab; 2006 Jul; 19(7):919-25. PubMed ID: 16995572
[TBL] [Abstract][Full Text] [Related]
15. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus].
Merola B; Caruso E; De Chiara G; Rossi E; Longobardi S; Colao A; Brusco G; Lombardi G; Biraghi M
Minerva Med; 1992 Dec; 83(12):805-13. PubMed ID: 1491760
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
Marín GR; Baspineiro B; Vilca I
Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
[TBL] [Abstract][Full Text] [Related]
19. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
Almutlaq N; Eugster EA
J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
Radó JP; Marosi J; Fischer J
Pharmacology; 1977; 15(1):40-5. PubMed ID: 840889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
